Atea Pharmaceuticals, Inc. AVIR Q4 2025 Annual earnings

FAQ

When did Atea Pharmaceuticals, Inc. report Q4 2025 earnings?

Atea Pharmaceuticals, Inc. (AVIR) reported Q4 2025 earnings on March 5, 2026 after market close.

What were Atea Pharmaceuticals, Inc.'s Q4 2025 revenue and EPS?

Atea Pharmaceuticals, Inc. reported eps of $-0.57 for Q4 2025.

Did Atea Pharmaceuticals, Inc. beat estimates in Q4 2025?

EPS missed the consensus estimate of $-0.49 by $0.08.

How did Atea Pharmaceuticals, Inc.'s Q4 2025 results compare year-over-year?

Compared to the same quarter a year prior, eps declined 42.5% from $-0.40.

Where can I find Atea Pharmaceuticals, Inc.'s Q4 2025 SEC filings?

You can read the 8-K earnings release (0001193125-26-093961) and the 10-K periodic report (0001193125-26-094159) directly on SEC EDGAR. The filing index links above go to sec.gov.